hyperlipoproteinemia type 3
Hyperlipoproteinemia (HLP) type 3 is a rare combined hyperlipidemia characterized by high levels of cholesterol and triglycerides, transported by intermediate density lipoproteins (IDLs), and a high risk of premature atherosclerosis and cardiovascular disease. [ Orphanet:412 ]
Term info
- MedDRA:10060751 (Orphanet:412/e)
- DOID:3145 (MONDO:equivalentTo)
- Orphanet:412 (OMIM:617347)
- SCTID:398796005 (MONDO:equivalentTo)
- OMIM:617347 (Orphanet:412)
- GARD:0006703 (MONDO:equivalentTo)
- UMLS:C0020479 (Orphanet:412/e)
- UMLS:C1862561 (MONDO:equivalentTo)
ordo_disease
http://identifiers.org/meddra/10060751
Hyperlipoproteinemia (HLP) type 3 is a rare combined hyperlipidemia characterized by high levels of cholesterol and triglycerides, transported by intermediate density lipoproteins (IDLs), and a high risk of premature atherosclerosis and cardiovascular disease.
http://identifiers.org/snomedct/398796005, http://purl.obolibrary.org/obo/Orphanet_412, http://purl.obolibrary.org/obo/DOID_3145, http://linkedlifedata.com/resource/umls/id/C0020479, https://omim.org/entry/617347, http://linkedlifedata.com/resource/umls/id/C1862561
dyslipidemia type 3, remnant hyperlipidemia, hyperlipidemia type 3, familial hyperlipoproteinemia type 3, familial dysbetalipoproteinemia, HLP type 3, remnant disease, familial type 3 hyperlipoproteinemia, carbohydrate induced hyperlipemia, hyperlipoproteinemia type III, Broad-betalipoproteinemia
dysbetalipoproteinemia due to defect in apolipoprotein E-D, familial hypercholesterolemia with hyperlipemia, dysbetalipoproteinemia, remnant removal disease, familial hypercholesterolaemia with hyperlipaemia, familial Hyperbeta- and Prebetalipoproteinemia, low density lipoprotein cholesterol level quantitative trait locus 5, hyperlipoproteinemia, type III, floating-betalipoproteinemia, hyperlipemia with Familial Hypercholesterolemic xanthomatosis, Broad beta disease, apolipoprotein E, deficiency or defect of, coronary artery disease, Severe, Susceptibility to
MONDO:0018473